Physician profile
Lauren Yancey
NPI 1386872950
$11,693.49
in general payments reported to CMS, 2019-2025
21 companies · $7,231 in 2025
The $7,231 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $120 · 2021: $219 · 2022: $220 · 2023: $221 · 2024: $2,689 · 2025: $7,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,400 · Travel and Lodging: $1,414 · Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,400.00 |
| Travel and Lodging | $1,414.21 |
| Food and Beverage | $1,325.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $10,556.29 | 2019-2025 | Clareon, Unity, Rocklatan |
| Amgen INC. | $170.21 | 2024-2025 | Tepezza |
| Glaukos Corporation | $142.03 | 2019-2024 | Idose, Istent Inject Trabecular Micro-Bypass System, Istent Trabecular Micro-Bypass System Model Is3 |
| Novartis Pharmaceuticals Corporation | $121.14 | 2019-2023 | |
| Dompe US, INC. | $108.24 | 2021-2025 | Oxervate |
| Abbvie INC. | $77.06 | 2024-2025 | |
| Allergan, INC. | $76.31 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $66.90 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Mallinckrodt Hospital Products INC. | $52.87 | 2021-2022 | |
| Ocular Therapeutix, INC. | $52.20 | 2023 | Dextenza |
| Akorn, INC. | $35.29 | 2019 | |
| Biotissue Holdings INC. | $32.10 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $30.83 | 2022-2025 | Tecnis Simplicity |
| Sight Sciences, INC. | $30.48 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $28.47 | 2023 | Cequa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $27.87 | 2019-2021 | |
| New World Medical,INC. | $20.06 | 2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Genentech USA, INC. | $19.89 | 2023 | Vabysmo |
| Bausch & Lomb Americas INC. | $19.18 | 2025 | Miebo |
| Omeros Corporation | $13.07 | 2019 | |
| Shire North American Group INC | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Yancey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.